TrialScientific reports2022

Convalescent plasma in the treatment of moderate to severe COVID-19 pneumonia: a randomized controlled trial (PROTECT-Patient Trial).

Karin van den Berg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.